China (Mainland)
Peptides Bivalirudin Trifluoroacetate CAS NO.128270-60-0
- FOB Price: USD: 3.00-5.00 /Gram Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: T/T,
- Available Specifications:
pharmaceutical grade(1-10)Grampharmaceutical grade(10-20)Gram
- Product Details
Keywords
- Bivalirudin Trifluoroacetate
- Atosiban
- peptides
Quick Details
- ProName: Peptides Bivalirudin Trifluoroacetate
- CasNo: 128270-60-0
- Molecular Formula: C98H138N24O33
- Appearance: White powder
- Application: Bodybuilding,Chemical,Research etc.
- DeliveryTime: within 3days
- PackAge: Fresco Bag,Vials
- Port: shanghai
- ProductionCapacity: 10000 Gram/Week
- Purity: 98%
- Storage: Store the shade
- Transportation: By Air,TNT,EMS,DHL,HKEUB
- LimitNum: 10 Gram
- Related Substances: Amino Acid
- Residue on Ignition: 0
- Heavy Metal: 0
- Valid Period: 2 years
- Categories: Rawder powder
Superiority
About Our Company
This is Grace from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.Our company is the peptides manufacturer(All products by Lab suppy),supplying:
1:Peptides(bodybuilding peptides and Cosmetic peptides)
2:Steroids( Powder,Oil,Pills)
3:Custom-made
We have Golden Forwarder to ensuer delievery safe,and pass Rate above 98%.
Looking forward to having a chance to cooperate with you.
Skype:ruoyu92
Whatsapp:+8618003706993
Email:filter-sales12@filterbio-technology.com
<
|
Peptides Hotsale Products List |
||
|
Pruduct Name |
Specification |
Purity |
|
HGH191AA |
10IU/vial |
0.98 |
|
HGH(176-191) |
2mg/vial |
0.98 |
|
GHRP-2 |
5mg/vial |
0.98 |
|
GHRP-6 |
5mg/vial |
0.99 |
|
CJC1295withdac |
2mg/vial |
0.988 |
|
CJC1295withoutdac |
2mg/vial |
98% |
|
Adipotide |
2mg/vial |
95% |
|
MT-II |
10mg/vial |
95%-99% |
|
PT-141 |
10mg/vial |
0.98 |
|
TB-500 |
2mg/vial |
0.98 |
|
IGF-1（1-3） |
2mg/vial |
95%-99% |
|
IGF-1 Lr3 |
1mg/0.1mg(vial) |
98% |
|
Tesamorelin |
2mg/vial |
95%-99% |
|
Epithalon |
10mg/vial |
95%-99.5% |
|
Hexarelin |
2mg/vial |
0.98 |
|
Triptorellin |
2mg/vial |
0.98 |
|
Ipamorelin |
2mg/vial |
0.98 |
|
Terlipressin Acetate |
10mg/vial |
0.98 |
|
Melanotan-I |
10mg/vial |
0.98 |
|
MGF |
2mg/vial |
0.98 |
|
PEG-MGF |
2mg/vial |
0.98 |
|
Sermorelin |
2mg/vial |
0.98 |
|
Desmopressin Acetate |
2mg/vial |
0.98 |
|
BCP-157 |
5mg/vial |
98% |
|
Nesiritide Acetate(BNP-32) |
2mg/vial |
98% |
|
Dynorphin A(1-13)Acetate |
5mg/vial |
98% |
|
HCG |
5000IU/vial |
|
|
Selank |
5mg/vial |
0.988 |
Details
Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS). It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics make bivalirudin an ideal alternative to heparin.
Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials
Application:
Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).
Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI.
Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.
Products
Our Lab
Freight
